BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015;110:749-759. [PMID: 25916221 DOI: 10.1038/ajg.2015.119] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Metz DC, Cadiot G, Poitras P, Ito T, Jensen RT. Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing. Int J Endocr Oncol 2017;4:167-85. [PMID: 29326808 DOI: 10.2217/ije-2017-0018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
2 Law EH, Badowski M, Hung Y, Weems K, Sanchez A, Lee TA. Association Between Proton Pump Inhibitors and Microscopic Colitis: Implications for Practice and Future Research. Ann Pharmacother 2017;51:253-63. [DOI: 10.1177/1060028016673859] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
3 Schubert ML. Functional anatomy and physiology of gastric secretion. Curr Opin Gastroenterol. 2015;31:479-485. [PMID: 26376477 DOI: 10.1097/MOG.0000000000000213] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
4 Rouphael C, Gordon IO, Thota PN. Lymphocytic esophagitis: Still an enigma a decade later. World J Gastroenterol 2017; 23(6): 949-956 [PMID: 28246468 DOI: 10.3748/wjg.v23.i6.949] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
5 Lei WY, Wang JH, Yi CH, Liu TT, Hung JS, Wong MW, Bair MJ, Vaezi MF, Orr WC, Chen CL. Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study. Clin Res Hepatol Gastroenterol 2021;45:101397. [PMID: 32224118 DOI: 10.1016/j.clinre.2020.02.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
6 Nyboe Andersen N, Munck LK, Hansen S, Jess T, Wildt S. All-cause and cause-specific mortality in microscopic colitis: a Danish nationwide matched cohort study. Aliment Pharmacol Ther 2020;52:319-28. [DOI: 10.1111/apt.15868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Vaezi MF, Yang YX, Howden CW. Complications of Proton Pump Inhibitor Therapy. Gastroenterology. 2017;153:35-48. [PMID: 28528705 DOI: 10.1053/j.gastro.2017.04.047] [Cited by in Crossref: 198] [Cited by in F6Publishing: 146] [Article Influence: 49.5] [Reference Citation Analysis]
8 Pardi DS. Diagnosis and Management of Microscopic Colitis. Am J Gastroenterol. 2017;112:78-85. [PMID: 27897155 DOI: 10.1038/ajg.2016.477] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 13.2] [Reference Citation Analysis]
9 Gentile N, Yen EF. Prevalence, Pathogenesis, Diagnosis, and Management of Microscopic Colitis. Gut Liver 2018;12:227-35. [PMID: 28669150 DOI: 10.5009/gnl17061] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
10 Jensen ET, Dellon ES. Environmental factors and eosinophilic esophagitis. J Allergy Clin Immunol 2018;142:32-40. [PMID: 29729305 DOI: 10.1016/j.jaci.2018.04.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
11 Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn AM, Wildt S, Bohr J, Bonderup O, Bouma G, D'Amato M, Heiberg Engel PJ, Fernandez-Banares F, Macaigne G, Hjortswang H, Hultgren-Hörnquist E, Koulaouzidis A, Kupcinskas J, Landolfi S, Latella G, Lucendo A, Lyutakov I, Madisch A, Magro F, Marlicz W, Mihaly E, Munck LK, Ostvik AE, Patai ÁV, Penchev P, Skonieczna-Żydecka K, Verhaegh B, Münch A. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J 2021. [PMID: 33619914 DOI: 10.1177/2050640620951905] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
12 Verhaegh BP, Bijnens EM, van den Heuvel TR, Goudkade D, Zeegers MP, Nawrot TS, Masclee AA, Jonkers DM, Pierik MJ. Ambient air quality as risk factor for microscopic colitis – A geographic information system (GIS) study. Environmental Research 2019;178:108710. [DOI: 10.1016/j.envres.2019.108710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Jauregui-amezaga A, Vermeire S, Geboes K. Contemporary methods for the diagnosis and treatment of microscopic colitis. Expert Review of Gastroenterology & Hepatology 2015;10:47-61. [DOI: 10.1586/17474124.2016.1096197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Clemente Actis G. The Changing Face of Inflammatory Bowel Disease: Etiology, Physiopathology, Epidemiology. Ann Colorectal Res 2016;4. [DOI: 10.17795/acr-32942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 雷招宝. 关注质子泵抑制剂的不良反应与合理用药. 世界华人消化杂志 2016; 24(23): 3468-3475 [DOI: 10.11569/wcjd.v24.i23.3468] [Reference Citation Analysis]
16 Chi Z, Xu J, Saxena R. Increased Mast Cell Counts and Degranulation in Microscopic Colitis. Gastroenterol Res Pract 2020;2020:9089027. [PMID: 32148478 DOI: 10.1155/2020/9089027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kung VL, Liu T, Ma C. Collagenous Enteritis is Unlikely a Form of Aggressive Celiac Disease Despite Sharing HLA-DQ2/DQ8 Genotypes. American Journal of Surgical Pathology 2018;42:545-52. [DOI: 10.1097/pas.0000000000001022] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Puga AM, Lopez-Oliva S, Trives C, Partearroyo T, Varela-Moreiras G. Effects of Drugs and Excipients on Hydration Status. Nutrients 2019;11:E669. [PMID: 30897748 DOI: 10.3390/nu11030669] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
19 Sandler RS, Keku TO, Woosley JT, Galanko JA, Peery AF. Medication use and microscopic colitis. Aliment Pharmacol Ther 2021;54:1193-201. [PMID: 34514632 DOI: 10.1111/apt.16594] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gyawali CP. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0586-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
21 Cotter TG, Pardi DS. Editorial: additional evidence for drug-induced microscopic colitis. Aliment Pharmacol Ther 2016;43:1343-4. [PMID: 27166985 DOI: 10.1111/apt.13624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
22 Nakaya Y, Kaku Hosokawa S, Kataoka Y, Hirabayashi M, Yamamoto S, Takasu K, Kitamura S, Omae T, Yoshimatsu Y. Acute onset collagenous colitis associated with protein-losing enteropathy. J Gen Fam Med 2017;18:135-8. [PMID: 29264009 DOI: 10.1002/jgf2.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Sonnenberg A, Turner KO, Genta RM. Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease. Colorectal Dis 2018;20:813-20. [DOI: 10.1111/codi.14114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hamdeh S, Micic D, Hanauer S. Drug-Induced Colitis. Clinical Gastroenterology and Hepatology 2021;19:1759-79. [DOI: 10.1016/j.cgh.2020.04.069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Rosenberg V, Tzadok R, Chodick G, Kariv R. Proton pump inhibitors long term use-trends and patterns over 15 years of a large health maintenance organization. Pharmacoepidemiol Drug Saf 2021;30:1576-87. [PMID: 34453456 DOI: 10.1002/pds.5352] [Reference Citation Analysis]
26 Burke KE, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H. Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women. J Crohns Colitis 2018;12:559-67. [PMID: 29370359 DOI: 10.1093/ecco-jcc/jjy005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
27 Ciciora SL, Woodley FW. Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux. Pediatr Drugs 2018;20:523-37. [DOI: 10.1007/s40272-018-0311-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Chamata Y, Watson KA, Jauregi P. Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors. Int J Mol Sci 2020;21:E864. [PMID: 32013233 DOI: 10.3390/ijms21030864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
29 Liu PH, Lebwohl B, Burke KE, Ivey KL, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H. Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort Study. Am J Gastroenterol 2019;114:127-34. [PMID: 30181535 DOI: 10.1038/s41395-018-0267-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Smoking and Risk of Microscopic Colitis: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2019;25:672-8. [PMID: 30869794 DOI: 10.1093/ibd/izy296] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
31 Grattagliano I, Ubaldi E, Portincasa P. Drug-induced enterocolitis: Prevention and management in primary care. J Dig Dis. 2018;19:127-135. [PMID: 29417737 DOI: 10.1111/1751-2980.12585] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
32 Solberg F, Ohlsson B. Microscopic colitis and its associations with complications observed in classic inflammatory bowel disease: a systematic review. Scand J Gastroenterol 2020;55:312-20. [PMID: 32182146 DOI: 10.1080/00365521.2020.1739325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Khalili H, Axelrad JE, Roelstraete B, Olén O, D'Amato M, Ludvigsson JF. Gastrointestinal Infection and Risk of Microscopic Colitis: A Nationwide Case-Control Study in Sweden. Gastroenterology 2021;160:1599-1607.e5. [PMID: 33421519 DOI: 10.1053/j.gastro.2021.01.004] [Reference Citation Analysis]
34 Okamoto R, Negi M, Tomii S, Eishi Y, Watanabe M. Diagnosis and treatment of microscopic colitis. Clin J Gastroenterol 2016;9:169-74. [DOI: 10.1007/s12328-016-0656-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
35 Park T, Cave D, Marshall C. Microscopic colitis: A review of etiology, treatment and refractory disease. World J Gastroenterol 2015; 21(29): 8804-8810 [PMID: 26269669 DOI: 10.3748/wjg.v21.i29.8804] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 25] [Article Influence: 7.2] [Reference Citation Analysis]
36 Burke KE, D'Amato M, Ng SC, Pardi DS, Ludvigsson JF, Khalili H. Microscopic colitis. Nat Rev Dis Primers 2021;7:39. [PMID: 34112810 DOI: 10.1038/s41572-021-00273-2] [Reference Citation Analysis]
37 Tome J, Kamboj AK, Pardi DS. Microscopic Colitis: A Concise Review for Clinicians. Mayo Clin Proc 2021;96:1302-8. [PMID: 33958059 DOI: 10.1016/j.mayocp.2021.03.022] [Reference Citation Analysis]
38 Green HD, Beaumont RN, Thomas A, Hamilton B, Wood AR, Sharp S, Jones SE, Tyrrell J, Walker G, Goodhand J, Kennedy NA, Ahmad T, Weedon MN. Genome-Wide Association Study of Microscopic Colitis in the UK Biobank Confirms Immune-Related Pathogenesis. J Crohns Colitis 2019;13:1578-82. [PMID: 31125052 DOI: 10.1093/ecco-jcc/jjz104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
39 Al Momani L, Balagoni H, Alomari M, Gaddam S, Boonpherg B, Aasen T, Piper M, Young M. The association between smoking and both types of microscopic colitis: A systematic review and meta-analysis. Arab J Gastroenterol 2020;21:9-18. [PMID: 32241698 DOI: 10.1016/j.ajg.2020.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lucendo AJ. Drug Exposure and the Risk of Microscopic Colitis: A Critical Update. Drugs R D 2017;17:79-89. [PMID: 28101837 DOI: 10.1007/s40268-016-0171-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
41 Bonderup OK, Nielsen GL, Dall M, Pottegård A, Hallas J. Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case-control study. Aliment Pharmacol Ther 2018;48:618-25. [PMID: 30039564 DOI: 10.1111/apt.14916] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
42 Verhaegh BPM, Pierik MJ, Goudkade D, Cuijpers YSMT, Masclee AAM, Jonkers DMAE. Early Life Exposure, Lifestyle, and Comorbidity as Risk Factors for Microscopic Colitis: A Case-Control Study. Inflamm Bowel Dis 2017;23:1040-6. [PMID: 28471835 DOI: 10.1097/MIB.0000000000001103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
43 Elias E, Targownik LE. The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events. Drugs 2019;79:715-31. [PMID: 30972661 DOI: 10.1007/s40265-019-01110-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
44 Zabana Y, Tontini G, Hultgren-Hörnquist E, Skonieczna-Żydecka K, Latella G, Østvik AE, Marlicz W, D'Amato M, Arias A, Mielhke S, Münch A, Fernández-Bañares F, Lucendo AJ. Pathogenesis Of Microscopic Colitis: A Systematic Review. J Crohns Colitis 2021:jjab123. [PMID: 34272945 DOI: 10.1093/ecco-jcc/jjab123] [Reference Citation Analysis]
45 Savarino V, Marabotto E, Furnari M, Zingone F, Zentilin P, Savarino E. Latest insights into the hot question of proton pump inhibitor safety - a narrative review. Dig Liver Dis. 2020;52:842-852. [PMID: 32513631 DOI: 10.1016/j.dld.2020.04.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
46 Verhaegh BPM, Münch A, Guagnozzi D, Wildt S, Cebula W, Diac AR, Fernández-bañares F, Al-khalaf MAR, Pedersen N, Kupcinskas J, Bohr J, Macaigne G, Lucendo AJ, Lyutakov I, Tontini G, Pigò F, Russo E, Hjortswang H, Miehlke S, Munck LK. Course of Disease in Patients with Microscopic Colitis: A European Prospective Incident Cohort Study. Journal of Crohn's and Colitis 2021;15:1174-83. [DOI: 10.1093/ecco-jcc/jjab007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
47 Resch A, Eherer A, Langner C. Pseudomembranes Carpet the Right Colon as a Result of Collagenous Colitis. Clinical Gastroenterology and Hepatology 2017;15:e95-6. [DOI: 10.1016/j.cgh.2016.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Burke KE, Ananthakrishnan AN, Lochhead P, Liu PH, Olen O, Ludvigsson JF, Richter JM, Tworoger SS, Chan AT, Khalili H. Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study. Gastroenterology 2018;155:1764-1775.e2. [PMID: 30144433 DOI: 10.1053/j.gastro.2018.08.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
49 Verhaegh BP, de Vries F, Masclee AA, Keshavarzian A, de Boer A, Souverein PC, Pierik MJ, Jonkers DM. High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther 2016;43:1004-13. [PMID: 26956016 DOI: 10.1111/apt.13583] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 13.8] [Reference Citation Analysis]
50 Bi W, Hu L, Man MQ. ANTI-ULCEROGENIC EFFICACY AND MECHANISMS OF EDIBLE AND NATURAL INGREDIENTS IN NSAID-INDUCED ANIMAL MODELS. Afr J Tradit Complement Altern Med 2017;14:221-38. [PMID: 28638885 DOI: 10.21010/ajtcam.v14i4.25] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Münch A. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol 2019;4:305-14. [PMID: 30860066 DOI: 10.1016/S2468-1253(19)30048-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 35.0] [Reference Citation Analysis]
52 Wallace JL. Eicosanoids in the gastrointestinal tract. Br J Pharmacol 2019;176:1000-8. [PMID: 29485681 DOI: 10.1111/bph.14178] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
53 Marlicz W, Skonieczna-żydecka K, Yung DE, Loniewski I, Koulaouzidis A. Endoscopic findings and colonic perforation in microscopic colitis: A systematic review. Digestive and Liver Disease 2017;49:1073-85. [DOI: 10.1016/j.dld.2017.07.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
54 Tome J, Sehgal K, Kamboj AK, Harmsen WS, Kammer PP, Loftus EV Jr, Tremaine WJ, Khanna S, Pardi DS. The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00691-1. [PMID: 34216819 DOI: 10.1016/j.cgh.2021.06.027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]